Novo Nordisk (NVO.N) shares rose more than 4% in pre-market trading in the U.S. as its weight loss drug Wegovy sales more than doubled in the fourth quarter of last year.

2025-02-05

Novo Nordisk (NVO.N) shares rose more than 4% in pre-market trading in the U.S. as its weight loss drug Wegovy sales more than doubled in the fourth quarter of last year.